Hydrocodone: Complete Guide to Uses, Dosage, Side Effects & Risks

Hydrocodone is one of the most widely prescribed opioid analgesics in the United States, known by familiar brand names such as Vicodin and Norco. For decades it was among the most dispensed prescription drugs in the country. While hydrocodone is an effective treatment for moderate to severe pain when used appropriately, it also carries significant risks of addiction, dependence, and overdose that every patient and prescriber must understand.

What Is Hydrocodone?

Hydrocodone is a semi-synthetic opioid analgesic and antitussive (cough suppressant) derived from codeine. It was first synthesized in Germany in 1920 and introduced to the US market in the 1940s. Originally used primarily as a cough suppressant, it later became one of the most commonly prescribed pain relievers in the country.

Hydrocodone is classified as a Schedule II controlled substance under the Controlled Substances Act. This reclassification from Schedule III to Schedule II occurred in 2014 when the DEA and FDA determined that the drug's abuse potential warranted stricter controls, reflecting the growing recognition of its role in the opioid epidemic.

Hydrocodone is available in the following formulations:

• Combination immediate-release products — hydrocodone paired with acetaminophen: Vicodin (5/300 mg, 7.5/300 mg, 10/300 mg), Norco (5/325 mg, 7.5/325 mg, 10/325 mg), Lortab, Lorcet, and generics
• Extended-release single-ingredient capsules — Zohydro ER (10 mg to 50 mg), for opioid-tolerant patients requiring around-the-clock pain management
• Extended-release combination tablet — Vicodin ER / Vicoprofen (hydrocodone with ibuprofen)

How Does Hydrocodone Work?

Hydrocodone primarily acts as an agonist at mu-opioid receptors (MOR) in the brain, spinal cord, and peripheral nervous system. Activation of these receptors inhibits the ascending pain pathway, reducing the perception and emotional response to pain. Hydrocodone also acts at kappa and delta opioid receptors, contributing to its analgesic and sedative effects.

In addition to its pain-relieving properties, mu-opioid receptor activation causes several physiologically important effects: slowed intestinal motility (constipation), respiratory depression (reduced drive to breathe), suppression of the cough reflex, and activation of the mesolimbic reward pathway, which releases dopamine and produces euphoria. This last effect is the primary neurobiological mechanism driving opioid addiction.

Hydrocodone is metabolized in the liver primarily by CYP2D6 and CYP3A4 enzymes. CYP2D6 converts approximately 10% of a hydrocodone dose to hydromorphone, a more potent opioid that contributes to analgesic effects. Importantly, patients who are CYP2D6 "ultra-rapid metabolizers" may convert more hydrocodone to hydromorphone, increasing both efficacy and risk. The half-life of immediate-release hydrocodone is approximately 4 hours.

Medical Uses of Hydrocodone

Hydrocodone combination products are approved for the relief of moderate to moderately severe pain. Extended-release hydrocodone (Zohydro ER) is approved for pain severe enough to require daily, around-the-clock opioid treatment in opioid-tolerant patients. Common clinical indications include:

• Post-surgical pain — short-term management following orthopedic, dental, abdominal, or other surgeries
• Dental pain — hydrocodone/acetaminophen combinations are frequently prescribed after tooth extractions and oral surgery
• Injury-related pain — fractures, sprains, soft tissue injuries
• Cancer pain — moderate cancer pain management, often as part of a step-up analgesic ladder
• Chronic non-cancer pain — severe cases where non-opioid treatment has proven insufficient, with careful risk assessment
• Cough suppression — some hydrocodone-containing cough syrups remain available by prescription for severe cough

The 2022 CDC Clinical Practice Guideline for Prescribing Opioids recommends that opioids be used at the lowest effective dose for the shortest duration necessary, and that non-opioid therapies should be tried first for chronic pain. Hydrocodone is not a first-line treatment for any pain condition.

Hydrocodone Dosage and Formulations

Dosing is individualized based on pain severity, opioid tolerance, renal and hepatic function, and patient age. For hydrocodone/acetaminophen combination products in opioid-naive adults:

Common Brand Names of Hydrocodone

Hydrocodone is known by many brand names, particularly in combination with acetaminophen. Understanding these names helps patients and families recognize hydrocodone products:

• Vicodin — historically the most recognized brand; contains hydrocodone and acetaminophen
• Norco — hydrocodone with 325 mg acetaminophen; among the most commonly prescribed forms today
• Lortab — hydrocodone/acetaminophen in tablet and liquid form
• Lorcet — hydrocodone with acetaminophen, higher acetaminophen content in older formulations
• Zohydro ER — extended-release single-ingredient hydrocodone; higher abuse and overdose risk due to lack of acetaminophen deterrent
• Hysingla ER — another extended-release single-ingredient hydrocodone product

Side Effects of Hydrocodone

Hydrocodone's side effects reflect the combined effects of its opioid component and, in combination products, its acetaminophen component.

Common Side Effects (Opioid-Related)

• Constipation — universal and does not improve with time. Stool softeners and laxatives should be started proactively when beginning hydrocodone therapy.
• Nausea and vomiting — especially during initiation; often improves after the first few days
• Drowsiness and sedation
• Dizziness and lightheadedness
• Headache
• Dry mouth
• Itching (pruritus)
• Euphoria or mood changes

Serious Side Effects

• Respiratory depression — the primary mechanism of opioid overdose death. Opioids reduce the drive to breathe, and high doses or combinations with other CNS depressants can cause breathing to stop entirely.
• Hepatotoxicity — from the acetaminophen component; particularly dangerous in patients with liver disease or who consume alcohol regularly
• Addiction and dependence — high risk with regular use
• Hormonal dysregulation — chronic use suppresses testosterone and other hormones
• Cognitive impairment — memory problems, difficulty concentrating
• Serotonin syndrome — rare but possible when combined with serotonergic medications

Hydrocodone vs Oxycodone: Comparison

Hydrocodone and oxycodone are frequently compared since both are widely prescribed for similar indications. Here are the key clinical differences:

• Potency: Oxycodone is approximately 1.5 times more potent than hydrocodone on a milligram-for-milligram basis.
• Formulations: Hydrocodone is most commonly prescribed as a combination product with acetaminophen; oxycodone is available both as a combination product and as a single-ingredient product (OxyContin).
• Metabolism: Hydrocodone is metabolized in part to hydromorphone by CYP2D6; oxycodone to oxymorphone by CYP2D6 and to noroxycodone by CYP3A4.
• Schedule: Both are Schedule II controlled substances following the 2014 reclassification of hydrocodone.
• Liver risk: Hydrocodone combination products carry additional liver toxicity risk from acetaminophen that oxycodone single-ingredient products do not.

Addiction, Physical Dependence, and the Opioid Epidemic

Hydrocodone products — particularly Vicodin — have been deeply implicated in the opioid crisis in the United States. For much of the 1990s and 2000s, Vicodin was the most prescribed drug in the country, with hundreds of millions of prescriptions dispensed annually. The widespread availability of hydrocodone contributed significantly to the current opioid epidemic, which has claimed hundreds of thousands of lives.

Physical dependence on hydrocodone develops with regular use. This means the body adapts to the drug's presence, and stopping or reducing the dose causes withdrawal symptoms. This is a physiological phenomenon, not a sign of weakness or moral failure. Withdrawal symptoms from hydrocodone include anxiety, restlessness, muscle aching, insomnia, sweating, goosebumps, runny nose, nausea, and vomiting.

Addiction — characterized by compulsive drug seeking despite harmful consequences — is a risk with hydrocodone, as with all opioids. Genetic predisposition, mental health conditions, previous substance use, and social factors all influence addiction risk. Patients who need long-term opioid therapy should be regularly screened for signs of problematic use using validated tools such as the ORT (Opioid Risk Tool).

Drug Interactions With Hydrocodone

Hydrocodone interacts dangerously with many commonly used medications. Always inform your healthcare provider and pharmacist about every medication, supplement, and recreational substance you use:

• Alcohol — severely potentiates CNS and respiratory depression; can be fatal even at moderate doses
• Benzodiazepines (Xanax, Valium, Ativan, Klonopin) — extremely dangerous combination; the FDA has issued a black box warning; responsible for the majority of opioid overdose fatalities
• Other opioids — additive respiratory depression
• Muscle relaxants (Flexeril, Soma) — additive CNS depression
• Sleep medications (Ambien, Lunesta) — increased respiratory depression risk
• MAO inhibitors — contraindicated within 14 days; risk of fatal serotonin syndrome
• CYP2D6 inhibitors (fluoxetine, paroxetine, bupropion) — may alter hydrocodone to hydromorphone conversion and affect efficacy/toxicity
• Acetaminophen-containing products — additional liver damage risk when combined with hydrocodone/APAP products

How Long Does Hydrocodone Stay in Your System?

Detection times for hydrocodone vary by testing method and individual factors including metabolism, hydration, kidney function, and the amount taken:

• Urine: 2 to 4 days for occasional users; up to 7 days for heavy or chronic users
• Blood: Up to 24 hours
• Saliva: 12 to 36 hours
• Hair follicle: Up to 90 days (this test reflects historical use over several months)

The analgesic effects of a single dose of immediate-release hydrocodone last 4 to 6 hours, which is shorter than the detection windows above. The presence of hydrocodone in a drug test does not necessarily indicate impairment at the time of testing.

Overdose: Recognition and Emergency Response

Hydrocodone overdose is a medical emergency that requires immediate action. The risk is greatest when hydrocodone is combined with other CNS depressants, when taken in higher doses than prescribed, or when used by someone without opioid tolerance. Warning signs include unresponsiveness or extreme sedation, very slow or absent breathing (fewer than 8 breaths per minute), choking or gurgling sounds, blue or grayish discoloration of lips and fingernails, and pinpoint pupils.

Emergency response: call 911 immediately; do not leave the person alone; administer naloxone (Narcan) if available — it rapidly reverses opioid effects and is available without a prescription in most US states; if the person is not breathing, begin CPR; place them in the recovery position if breathing. Naloxone may need to be re-administered as its effects last only 30 to 90 minutes, shorter than the duration of most opioids.